IRIS staging is the framework most veterinarians use to organize chronic kidney disease in dogs and to predict what needs attention next. The core stage is based on kidney filtration markers—most commonly creatinine and/or SDMA—interpreted when your dog is stable and well-hydrated. These values help estimate how reduced filtration has become, but they don’t tell the whole story.
That’s where IRIS “sub-staging” comes in. UPC (urine protein:creatinine) identifies proteinuria, which can signal ongoing kidney damage and often changes treatment priorities. Blood pressure is assessed because hypertension can accelerate progression and increase the risk of complications; controlling it can be kidney-protective and comfort-protective.
What does staging actually predict? Primarily, progression risk and monitoring frequency. Earlier stages may be followed with periodic lab trends, urine testing, and blood pressure checks; later stages typically require tighter rechecks and faster adjustments when appetite, hydration status, or lab values shift. Staging also helps your vet prioritize interventions—such as renal diet and phosphate control when indicated, anti-nausea and appetite support when symptoms appear, and CKD-specific fluid strategies for dogs who need them—without relying on guesswork. Ask your veterinarian which marker is driving your dog’s stage, whether UPC or blood pressure changes the risk category, and what recheck interval they recommend based on recent trends.